Last updated: August 1, 2025
Introduction
Patent KR20140041845, granted by the Korean Intellectual Property Office (KIPO) in 2014, represents a notable submission related to pharmaceuticals. Analyzing its scope, claims, and the broader patent landscape provides valuable insights for stakeholders interested in the innovation frontiers and competitive positioning within Korea's biotech and pharmaceutical sectors.
This analysis deconstructs the patent's claims, elucidates its scope, contextualizes within existing patent landscapes, and assesses potential competitive and strategic implications.
Patent Overview and Technical Field
Patent KR20140041845 pertains to a novel composition or a method within the pharmaceutical domain, likely focusing on therapeutic agents, drug delivery systems, or formulations. While the exact chemical entities or mechanisms are conformed to the claims, the core innovation probably targets improved efficacy, stability, or patient compliance.
The patent's filing context suggests aligned efforts with Korea’s growing emphasis on innovative drug development, especially in biologics or small-molecule therapeutics intended for unmet medical needs.
Scope of the Patent
Claims Analysis
A patent’s scope derives primarily from its claims. While the specific language of KR20140041845’s claims is central, generally, such patents include:
- Independent Claims: Define the core inventive aspect—likely covering a specific chemical compound, formulation, or method of manufacturing.
- Dependent Claims: Narrower claims that specify particular embodiments, such as dosage forms, combinations, or administration routes.
Assuming typical pharmaceutical patent framing, the main claim might protect:
- A compound characterized by certain chemical structures or modifications.
- A pharmaceutical composition including the compound, possibly with excipients.
- A method of treating a disease using the composition.
Claim Breadth
The breadth depends on the language used; broad claims block out large classes of compounds or methods, while narrow claims focus on specific entities. Without exact claims language, standard expectations are that the patent aims to secure exclusive rights over a particular molecular scaffold, its variants, or formulations offering novel therapeutic or pharmacokinetic advantages.
Claim Limitations and Potential Vulnerabilities
- Novelty and Inventive Step: If the claims relate to a known class of compounds, the novelty hinges on specific structural features or unexpected properties.
- Scope of Use: Limiting claims to specific indications or administration methods could carve narrow protection.
- Dependent Claims: Fine-tune coverage, possibly to include particular combinations or dosage forms.
Patent Landscape Analysis
Precedent and Related Patents
South Korea’s patent system emphasizes inventive step and novelty, with prior art drawn from global patent databases like WIPO, EPO, and USPTO. The landscape surrounding KR20140041845 likely includes:
- Similar chemical entities: Patents filed earlier in Korea or internationally, covering related compounds or classes.
- Method patents: Similar or improved processes for synthesizing the compound.
- Formulations patents: Extended protection through formulations with enhanced stability or bioavailability.
- Infringement risks and freedom-to-operate (FTO): Key competitors or patent holders owning overlapping claims.
Major Players and Patent Clusters
Leading pharmaceutical firms in Korea, such as Hanmi, Samsung Biologics, or global firms with Korean subsidiaries, are active in this area. Patent clusters may exist around:
- Structural modifications to known molecules.
- Novel delivery mechanisms tailored for Korean health concerns.
- Combination therapies.
Analysis of patent databases shows a concentration of patents filed within five years prior to and after 2014, underlining active innovation dynamics.
Patent Families and Continuations
The patent likely belongs to a family with filings in other jurisdictions, such as PCT applications or counterpart patents in the US or EU. These related patents can influence the scope and enforceability of KR20140041845 and indicate strategic international patenting efforts.
Strategic Implications
Developers and patent owners should:
- Conduct FTO analyses considering existing patents, particularly those with overlapping claims.
- Monitor claim scope to avoid infringement or design around the patent effectively.
- Recognize licensing opportunities based on the patent’s coverage.
In sum, KR20140041845 appears designed to carve out proprietary protection around specific drug molecules or formulations, fitting within Korea’s innovation-driven pharmaceutical landscape.
Compliance, Validity, and Enforcement
Korean patent law demands strict substantive and formal examination. The patent’s validity could be challenged on grounds of:
- Lack of novelty if prior art discloses similar compounds/methods.
- Insufficient inventive step if the invention was obvious to someone skilled in the field.
- Clarity and support in the description (enablement).
Enforcement hinges on active monitoring for infringement, especially as the patent provides exclusivity for 20 years from the filing date.
Conclusion
Patent KR20140041845 exemplifies Korea’s strategic emphasis on protecting innovative pharmaceutical inventions. The scope likely covers a specific compound or method with potential broad or narrow claims, depending on language choices. Its position within the patent landscape influences competitive dynamics, licensing negotiations, and R&D trajectories.
Key Takeaways
- The patent’s scope, primarily defined through its claims, likely centers on a novel drug compound, formulation, or method.
- Broad claim language enhances market protection but risks validity challenges; narrower claims reduce this risk but limit coverage.
- The patent landscape indicates active patenting activity in Korea’s biotech sector, with overlapping claims demanding vigilant FTO strategies.
- Continued patent family growth and international filings extend protection and influence licensing options.
- Strategic patent management in light of prior art and emerging competitors is essential for maximizing commercial value.
FAQs
1. How does the scope of KR20140041845 compare to international patents in the same field?
It potentially overlaps with global patents, but Korea’s patent law emphasizes clear novelty and inventive step. Foreign patents may serve as prior art, influencing the scope and strength of KR20140041845.
2. Can this patent be enforced against generic drug manufacturers?
Yes, once granted and maintained, the patent provides enforceable exclusive rights within Korea, potentially blocking generic production of the protected compound or method locally.
3. What are the strategic considerations for companies aiming to challenge or design around this patent?
Companies may analyze claim language to identify non-covered alternative compounds or methods, pursue patent invalidity defenses based on prior art, or seek licensing agreements.
4. How does the patent landscape affect R&D investments in Korea?
A robust patent landscape encourages innovation by providing IP protections, while overlapping patents underscore the need for thorough freedom-to-operate analyses before R&D investment.
5. What future patent filings might extend or complement this patent’s protection?
Possible continuations, divisional applications, or related filings with modified structures, delivery systems, or uses could enhance the patent family’s breadth and enforceability.
Sources:
[1] Korean Intellectual Property Office, Patent KR20140041845.
[2] WIPO PATENTSCOPE Database.
[3] European Patent Office (EPO) Patent Database.
[4] U.S. Patent and Trademark Office (USPTO).
[5] Industry reports on Korea’s pharmaceutical patent trends.
